Jang Dai-Ja, Lee Myeong Soo, Shin Byung-Cheul, Lee Young-Cheoul, Ernst Edzard
Korea Food Research Institute, Sungnam, South Korea.
Br J Clin Pharmacol. 2008 Oct;66(4):444-50. doi: 10.1111/j.1365-2125.2008.03236.x. Epub 2008 Jun 9.
Korean red ginseng (unskinned Panax ginseng before it is steamed or otherwise heated and subsequently dried) is one of the most widely used herbal remedies. This systematic review evaluates the current evidence for the effectiveness of red ginseng for treating erectile dysfunction.
Systematic searches were conducted on 20 electronic databases without language restrictions. Hand-searches included conference proceedings and our files. All randomized clinical studies (RCT) of red ginseng as a treatment of erectile dysfunction were considered for inclusion. Methodological quality was assessed using the Jadad score.
Seven RCTs met all the inclusion criteria. Their methodological quality was low on average. Six of the included RCTs compared the therapeutic efficacy of red ginseng with placebo. The meta-analysis of these data showed a significant effect (n = 349, risk ratio, 2.40; 95% CI of 1.65, 3.51, p < 0.00001, heterogeneity: tau(2) = 0.05, chi(2) = 6.42, p = 0.27, I(2) = 22%). Subgroup analyses also showed beneficial effects of red ginseng in psychogenic erectile dysfunction (n = 135, risk ratio, 2.05; 95% CI of 1.33, 3.16, p = 0.001, heterogeneity: chi(2) = 0.08, p = 0.96, I(2) = 0%).
Collectively these RCTs provide suggestive evidence for the effectiveness of red ginseng in the treatment of erectile dysfunction. However, the total number of RCTs included in the analysis, the total sample size and the methodological quality of the primary studies were too low to draw definitive conclusions. Thus more rigorous studies are necessary.
高丽参(未去皮的人参,经蒸煮或其他加热方式处理后干燥)是使用最广泛的草药疗法之一。本系统评价评估了高丽参治疗勃起功能障碍有效性的现有证据。
对20个无语言限制的电子数据库进行系统检索。手工检索包括会议论文集和我们的存档资料。纳入所有将高丽参作为勃起功能障碍治疗方法的随机临床研究(RCT)。使用Jadad评分评估方法学质量。
7项RCT符合所有纳入标准。它们的方法学质量平均较低。纳入的RCT中有6项比较了高丽参与安慰剂的治疗效果。对这些数据的荟萃分析显示有显著效果(n = 349,风险比为2.40;95%置信区间为1.65至3.51,p < 0.00001,异质性:tau(2) = 0.05,chi(2) = 6.42,p = 0.27,I(2) = 22%)。亚组分析还显示高丽参对心因性勃起功能障碍有有益效果(n = 135,风险比为2.05;95%置信区间为1.33至3.16,p = 0.001,异质性:chi(2) = 0.08,p = 0.96,I(2) = 0%)。
总体而言,这些RCT为高丽参治疗勃起功能障碍的有效性提供了提示性证据。然而,分析中纳入的RCT总数、总样本量以及原始研究的方法学质量过低,无法得出明确结论。因此需要更严谨的研究。